Levalbuterol Dosing and Administration Guidelines
Introduction to Levalbuterol Dosing
- In acute exacerbations, levalbuterol can be administered at half the milligram dose of racemic albuterol for comparable efficacy, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 2
Acute Exacerbation Dosing
- For children with acute exacerbations, the American Academy of Pediatrics recommends 0.075 mg/kg (minimum 1.25 mg) of levalbuterol, with a maximum dose of 1.25 mg 3
- Initial treatment for children with acute exacerbations: 0.31-1.25 mg every 20 minutes for 3 doses, followed by maintenance of 0.31-1.25 mg every 1-4 hours as needed, according to the American Academy of Pediatrics 1, 2
- Initial treatment for adults with acute exacerbations: 0.63-1.25 mg every 20 minutes for 3 doses, followed by maintenance of 0.63-1.25 mg every 1-4 hours as needed, as recommended by the American College of Allergy, Asthma, and Immunology 2
Metered-Dose Inhaler (MDI) Dosing
- Levalbuterol HFA: 45 mcg/puff, with the same dosing schedule as albuterol MDI (4-8 puffs every 20 minutes for acute symptoms), as recommended by the American Academy of Allergy, Asthma, and Immunology 1
- A spacer/valved holding chamber must be used, especially for children <4 years, according to the American Academy of Pediatrics 2
Key Dosing Principle: Half-Dose Equivalence
- Levalbuterol administered at half the milligram dose of racemic albuterol provides comparable efficacy and safety, as established by the American College of Allergy, Asthma, and Immunology 1, 2, 4
Administration Guidelines
- Use oxygen as the preferred gas source for nebulization at 6-8 L/min flow rate, as recommended by the American Academy of Pediatrics 4, 3
- Dilute to minimum 3 mL total volume with normal saline, according to the American Academy of Pediatrics 3
Monitoring Requirements
- Monitor heart rate, respiratory rate, work of breathing, and oxygen saturation after each treatment, as recommended by the American Academy of Pediatrics 3
- Watch for tachycardia, tremor, and hypokalemia, especially with frequent or high-dose administration, according to the American College of Allergy, Asthma, and Immunology 3